Стадирование рака пищевода и пищеводно-желудочного перехода по классификации TNM (UICC, 8-е издание)

Издание классификации TNM в 8-й редакции для рака пищевода (РП) и пищеводно-желудочного перехода (ПЖП), выпущенное в 2017 г., было значимо обновлено по сравнению с 7-м изданием. Восьмое издание классификации AJCC/TNM РП было пересмотрено на основе мета-анализа группы международного сотрудничества по РП (Worldwide Esophageal Cancer Collaboration, WECC). Изменения стадирования в 8-м издании классификации РП основывались на показателях общей выживаемости больных РП, перенесших хирургическое лечение или хирургическое лечение с предоперационной и / или послеоперационной терапией в отличие от 7-го издания, которое было основано на данных пациентов, перенесших только хирургическое лечение. В новом издании по стадированию РП и ПЖП представлены отдельные классификации для групп клинических (cTNM), гистологических (pTNM) и гистологических после неоадьювантного лечения (ypTNM) стадий. Проанализированы основные различия между 7-м и 8-м изданиями классификации AJCC/TNM для РП.

1. Ajani JA, D'Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers, Version 2. 2023, NCCN Clinical Practice Guidelines in Oncology. Volume 21: Issue 4. Online Publication Date: Apr 2023. https://doi.org/10.6004/jnccn.2023.0019.

2. World Health Organization. Oesophagus. Accessed January 13, 2023. Available at: http://gco.iarc.fr/today/data/fact-sheets/cancers/6-Oesophagus-fact-sheet.pdf.

3. Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48. https://doi.org/10.3322/caac.21763

4. Then EO, Lopez M, Saleem S, et al. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol. 2020 Apr; 11(2):55-64. https://doi.org/10.14740/wjon1254.

5. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660.

6. Каприн АД, Старинский ВВ, Шахзадова АО. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022. 252 с. ISBN 978-5-85502-280-3.

7. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001; 30:1415-25. https://doi.org/10.1093/ije/30.6.1415.

8. National Comprehensive Cancer Network. Esophageal and Esophagogastric Junction Cancers (Version4.2020). https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.

9. Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76:S1367-9. https://doi.org/10.1016/s0003-4975(03)01202-5

10. Lagergren J, Bergstrom R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000;85:340-6. https://doi.org/10.1002/(SICI)1097-0215(20000201)85:3%3C340::AID-IJC8%3E3.0.CO;2-N

11. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404-13. https://doi.org/10.1093/jnci/djg047.

12. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424-33. https://doi.org/10.1093/aje/kwm051.

13. Cook MB, Kamangar F, Whiteman DC, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344-53. https://doi.org/10.1093/jnci/djq289.

14. Wang QL, Xie SH, Li WT, et al. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J Natl Cancer Inst. 2017;109:djx115. https://doi.org/10.1093/jnci/djx115.

15. Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends — an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16-27. https://doi.org/10.1158/1055-9965.EPI-15-0578.

16. Turati F, Tramacere I, La Vecchia C, et al. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24:609-17. https://doi.org/10.1093/annonc/mds244.

17. Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol. 2011;35:309-19. https://doi.org/10.1016/j.canep.2011.03.001.

18. Clinical recommendation for esophageal and gastric cardia cancers. https://oncology-association.ru/wp-content/uploads/2021/04/kr_rak-pishhevoda-i-kardii_aor_30.03.2021. pdf.

19. Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537-41. https://doi.org/10.1023/a:1024715824149.

20. van de Ven SEM, Falger JM, Verhoeven RHA, et al. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population. United European. Gastroenterol J. 2021:9. https://doi.org/10.1177/2050640620977129.

21. Zhang D, Zheng Y, Wang Z, et al. Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery. Eur J Surg Oncol (EJSO) October 2017;43(10):1949-55. https://doi.org/10.1016/j.ejso.2017.06.005 .

22. Brierly JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumor. Eight edition.

23. Wang F, Ge X, Wang Z, Weng Y, et al. Clinical significance and prognosis of supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Ann Transl Med. 2020 Feb;8(4):90. https://doi.org/10.21037/atm.2019.12.118

24. Jiang D, Wang H, Song Q, et al. Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification Comparison of the prognostic difference between. J Cancer. 2020;11(7):1808-15. https://doi.org/10.7150/jca.34567,

25. Daiko H, Kato K. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer. Jap J Clin Oncol. August 2020;50(8):847-51. https://doi.org/10.1093/jjco/hyaa082.

26. Kexing Xi, Hui Yu. Proposed Modification of the pN2 Classification of the 8th Edition AJCC Staging System for Esophageal Squamous Cell Carcinoma: A Preliminary Study Based on the Chinese Population J Oncol. Volume 2021, Article ID 8871884, 8 pages. https://doi.org/10.1155/2021/8871884.

27. Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Diseases of the Esophagus. 2009;22(1):1-8. https://doi.org/10.1111/j.1442-2050.2008.00901.x.

28. Amin MB, Edge S, Greene F, et al, editors. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 8th. New York: Springer International; 2017. https://doi.org/10.3322/caac.21388.

29. Zhang HL, Chen LQ, Liu R-L, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. Dis Esophagus. 2010;23(1):53-8. https://doi.org/10.1111/j.1442-2050.2009.00971.x.28.

30. Chen J, Pan J, Zheng X, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol. Biol. Phys. 2012;82(1):475-82. https://doi.org/10.1016/j.ijrobp.2010.08.037.

31. Peyre CG, Hagen JA, DeMeester SR, et al. Predicting Systemic Disease in Patients with Esophageal Cancer after Esophagectomy. Ann Surgery. 2008;248(6):979-85. https://doi.org/10.1097/sla.0b013e3181904f3c.

32. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease. Semin Radiat Oncol 2007;17:38-44. https://doi.org/10.1016/j.semra-donc.2006.09.007.

33. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-6

34. Oshikiri T, Goto H, Kato T, et al. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification Eur J Surg Oncol. 2022 Aug;48(8):1760-7. https://doi.org/10.1016/j.ejso.2022.01.014.

35. Schuring N, Matsuda S, ERS Hagens, et al. Diseases of the Esophagus. October 2021;34(10):doab009, https://doi.org/10.1093/dote/doab009